Table 3.

Patient clinical characteristics and outcomes.

Clinical characteristic	N = 18
Age (median)	60 years
BMI (median)	36.2
Race/Ethnicity Missing 1	White/Caucasian, n = 11 Black/African American, n = 2 Asian/Middle Eastern, n = 1 Hispanic/American Indian/Pacific Islander, n = 3
Cancer site	Uterine, n = 6, Ovarian, n = 8, Cervical, n = 1, Un- or De-differentiated, n = 3
Stage Missing 2	III, n = 6 IV, n = 10
Grade	High/grade3, n = 17 Low/grade1, n = 1
Disease status	New Dx, n = 12 New Recurrence, n = 6
Treatment n = 9	Platinum containing, n = 5 Taxol containing, n = 6 Bevacizumab, n = 1 Anti-CD47, n = 2
Presenting serum labs (mean)	Creatinine 4.1 mg/dL Potassium 5.2 mEq/L Uric Acid 14.1 mg/dL Calcium 8.0 mg/dL Phosphate 6.1 mg/dL
Outcome Missing1	Dead, n = 12 Alive not treating, n = 2 Alive and treating, n = 3